Cancer Trials Ireland > Articles by: ICORG

ICORG

Professor John Crown proposes a “virtual” National Cancer Research Centre of Ireland

Prof John Crown will chair a meeting in the Herbert Park hotel tomorrow, Friday 14th of June, to discuss the feasibility a “virtual” National Cancer Research Centre of Ireland.

The event is hosted by Molecular Therapeutics for Cancer Ireland (MTCI) and includes international experts, Sir Philip Cohen from Dundee, Prof Ulrik Ringborg from Sweden and Dr Mel Sorensen from the US, who will provide insight into international models for cancer research centres.
 

ICORG opens ANGIOPREDICT study in Ireland and Germany

The ANGIOPREDICT prospective translational study is an Exploratory Phase II clinical trial comprising biomarker analysis of oxaliplatin plus fluorouracil/leucovorin (FOLFOX) in combination with bevacizumab (bvz) in first line treatment of metastatic colorectal cancer (CRC) expressing mutant K-ras – AC-ANGIOPREDICT’.

Integrative Methods for Prostate Cancer Research MMI Course

Integrative methods for prostate cancer research: bridging molecular and population science on 14 June 2013.

This one-day course will provide in-depth exposure to fundamentals of epidemiology and molecular pathology of prostate cancer.

International Clinical Trials Day

Each year the International Clinical Trials Day is celebrated around the world on or near the 20th of May to celebrate the day that James Lind began his controlled trial comparing the different treatments for scurvy on the 20th May 1747.

World Ovarian Cancer Day 8th May 2013

8th May 2013 is the first World Ovarian Cancer Day. Ovarian cancer has the lowest survival rate of all gynecologic cancers, and is characterized around the world by a lack of awareness of symptoms and late stage diagnosis.